US FDA declines to approve PTC Therapeutics' rare genetic disorder drug
Summary
The U.S. Food and Drug Administration has declined to approve PTC Therapeutics' drug to treat a rare genetic disorder th...
The U.S. Food and Drug Administration has declined to approve PTC Therapeutics' drug to treat a rare genetic disorder that causes progressive damage to the nervous system, the company said on Tuesday, delaying a potential treatment for patients with limited treatment options.
Tags
PTC